Education
About Us
Working with TipRanks
Follow Us
Neuronetics Inc (STIM)
NASDAQ:STIM
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.08Last Year’s EPS
-0.33Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: -14.89%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted robust revenue growth driven by the Greenbrook acquisition and successful execution of strategic initiatives such as the BMP program and SPRAVATO rollout. However, challenges were noted in terms of decreased gross margin, increased operating expenses, and a widened net loss. Despite these challenges, the company remains on track to achieve cash flow positivity by the third quarter.Company Guidance
During the Neuronetics First Quarter 2025 Financial and Operating Results Conference Call, significant guidance was provided with several key metrics highlighted. The company reported a total revenue of $32 million, marking an 84% increase over the first quarter of 2024. Pro forma revenue increased by 7% to $29.8 million compared to the same period last year. Key performance metrics included NeuroStar system revenue at $2.8 million with 31 systems shipped, U.S. treatment session revenue at $9.6 million, and U.S. Clinic revenue, attributed to the Greenbrook acquisition, at $18.7 million. The gross margin was reported at 49%, a decrease from 75% in the prior year, primarily due to the inclusion of the Greenbrook clinic business. Operating expenses increased by 35% to $26.8 million, largely due to the addition of Greenbrook's operating costs. The company also reported a net loss of $12.7 million, or $0.21 per share. Strategic initiatives such as the Greenbrook integration, SPRAVATO rollout, and the expansion of the Better Me Provider program were emphasized as core growth drivers. Neuronetics aims to achieve cash flow positivity by the third quarter of 2025, supported by their enhanced capital position following a public offering that raised $18.9 million. The company maintained its full-year revenue guidance at $149 million to $155 million, with expectations of a 55% gross margin for the year.Significant Revenue Growth
Total revenue was $32 million, an increase of 84% over the first quarter of 2024. On a pro forma basis, total revenue increased 7% over pro forma revenue of $29.8 million for the first quarter of 2024.
Successful Greenbrook Integration
The integration of Greenbrook has been effective, with 95% of identified synergies realized by the end of 2024, and expectations to exceed $23 million in total realized synergies.
SPRAVATO Rollout Progress
SPRAVATO is now offered in 75 of the 95 Greenbrook clinics, up from 35 clinics at the beginning of the quarter, with Buy & Bill treatments generating approximately 3x the revenue compared to the administer and observe model.
Expansion of BMP Program
The BMP program includes over 385 active sites, with sites in the program treating three times more patients per site per quarter than non-participating practices.
Adolescent Treatment Growth
The number of adolescent patients receiving treatment grew by 38% in the first quarter of 2025 compared to the first quarter of 2024.
STIM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
STIM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $4.50 | $4.50 | 0.00% |
Mar 04, 2025 | $4.26 | $5.06 | +18.78% |
Nov 12, 2024 | $1.10 | $0.69 | -37.27% |
Aug 12, 2024 | $1.78 | $0.74 | -58.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Neuronetics Inc (STIM) report earnings?
Neuronetics Inc (STIM) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is Neuronetics Inc (STIM) earnings time?
Neuronetics Inc (STIM) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STIM EPS forecast?
STIM EPS forecast for the fiscal quarter 2025 (Q2) is -0.08.